Oral Vaccination against Bubonic Plague Using a Live AvirulentYersinia pseudotuberculosisStrain
Open Access
- 1 August 2008
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (8) , 3808-3816
Abstract
We evaluated the possibility of usingYersinia pseudotuberculosisas a live vaccine against plague because it shares high genetic identity withY. pestiswhile being much less virulent, genetically much more stable, and deliverable orally. A total of 41Y. pseudotuberculosisstrains were screened by PCR for the absence of the high pathogenicity island, the superantigens YPM, and the type IV pilus and the presence of the pYV virulence plasmid. One strain (IP32680) fulfilled these criteria. This strain was avirulent in mice upon intragastric or subcutaneous inoculation and persisted for 2 months in the mouse intestine without clinical signs of disease. IP32680 reached the mesenteric lymph nodes, spleen, and liver without causing major histological lesions and was cleared after 13 days. The antibodies produced in vaccinated animals recognized bothY. pseudotuberculosisandY. pestisantigens efficiently. After a subcutaneous challenge withY. pestisCO92, bacteria were found in low amounts in the organs and rarely in the blood of vaccinated animals. One oral IP32680 inoculation protected 75% of the mice, and two inoculations induced much higher antibody titers and protected 88% of the mice. Our results thus validate the concept that an attenuatedY. pseudotuberculosisstrain can be an efficient, inexpensive, safe, and easy-to-produce live vaccine for oral immunization against bubonic plague.Keywords
This publication has 51 references indexed in Scilit:
- Current challenges in the development of vaccines for pneumonic plagueExpert Review of Vaccines, 2008
- Yersinia pestis CO92Δ yopH Is a Potent Live, Attenuated Plague VaccineClinical and Vaccine Immunology, 2007
- Multiple Antimicrobial Resistance in Plague: An Emerging Public Health RiskPLOS ONE, 2007
- Vaccination with Live Yersinia pestis Primes CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary Y. pestis InfectionInfection and Immunity, 2007
- Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide responseNature Immunology, 2006
- Evaluation of O-antigen inactivation on Pla activity and virulence of Yersinia pseudotuberculosis harbouring the pPla plasmidMicrobiology, 2005
- Yersinia pseudotuberculosis Harbors a Type IV Pilus Gene Cluster That Contributes to PathogenicityInfection and Immunity, 2002
- Genome sequence of Yersinia pestis, the causative agent of plagueNature, 2001
- Multidrug Resistance inYersinia pestisMediated by a Transferable PlasmidNew England Journal of Medicine, 1997
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988